+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Fibroblast Growth Factor 2 Market - Global Forecast 2025-2030- Product Image
Human Fibroblast Growth Factor 2 Market - Global Forecast 2025-2030- Product Image
Sale

Human Fibroblast Growth Factor 2 Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145627
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Human Fibroblast Growth Factor 2 (FGF2) occupies a pivotal position as a key enabler of regenerative medicine, with impact across clinical, research, and manufacturing ecosystems. As evolving biotechnologies and regulatory shifts shape production and application methods, FGF2-based solutions offer distinct opportunities for strategic growth and collaboration.

Market Snapshot: Human Fibroblast Growth Factor 2

The Human Fibroblast Growth Factor 2 market is driven by advances in expression technologies, expanding clinical use, and rising investments from both public and private sector actors. Transformative developments in recombinant DNA and downstream processing have significantly improved FGF2 purity and consistency. This progress, coupled with innovative delivery systems and strong regulatory engagement, is propelling expansion across biopharmaceutical, healthcare, and life sciences sectors, underpinned by rising global demand for advanced therapeutic solutions.

Scope & Segmentation of the Human Fibroblast Growth Factor 2 Market

This report offers a deep dive into the market’s multi-dimensional landscape, detailing all critical segmentation and application pathways. Segments analyzed include:

  • Applications: Cancer therapy, cosmetic formulations, research, drug delivery—including hydrogel, liposome, and nanoparticle delivery—and tissue engineering categories such as bone, cardiac, neural, and skin regeneration.
  • Expression Systems: CHO cells, E. coli, insect cells, and yeast platforms, each contributing distinct benefits to yield, modification fidelity, or regulatory acceptance.
  • End Users: Academic research institutes, biotechnology companies, contract research organizations, hospitals and clinics, and pharmaceutical developers.
  • Product Forms: Liquid solutions and lyophilized powders, each affecting logistics, stability, and compatibility with intended applications.
  • Purity Grades: Categories include 95 to 99 percent, less than 95 percent, and higher than 99 percent purity levels, guiding suitability for specific research or therapeutic uses.
  • FGF2 Types: Natural human and recombinant human variants, with sourcing and regulatory pathways influencing adoption and product development.
  • Geographic Regions: Americas (with focus on leading US states and neighboring countries), Europe, Middle East & Africa (including major economies and emerging biotech markets), and Asia-Pacific (spanning leading and fast-developing markets).
  • Key Players: Leading companies include Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Abcam plc, STEMCELL Technologies Inc., Promega Corporation, Lonza Group AG, RayBiotech Inc., Sino Biological Inc., and ProSpec-Tany Technogene Ltd.

Key Takeaways for Decision Makers

  • FGF2’s mitogenic and pro-angiogenic functions position it at the forefront of translational research, facilitating new drug delivery platforms and tissue repair protocols.
  • Biologic production has seen notable improvements through recombinant expression, innovative formulation, and purification approaches, supporting scale-up and greater bioactivity.
  • Emerging delivery technologies—including hydrogels and nanoparticle-based systems—are fostering precise administration while improving stability and therapeutic outcomes.
  • Collaborative frameworks across academia, contract organizations, and commercial ventures are accelerating clinical validation and reducing development timelines.
  • Regulatory authorities are rapidly adapting to advanced biologics, streamlining approval processes and ensuring robust safety assessment for novel FGF2 therapies.
  • Optimizing supply chain resilience remains a key concern, driving investment in local manufacturing and diverse sourcing strategies to maintain continuity and product flow.

Tariff Impact: Navigating 2025 U.S. Policy Changes

Recent United States tariff adjustments have increased the cost of importing FGF2 raw materials and specialized reagents, creating new complexities for research and production facilities. Resulting delays in acquiring critical components have highlighted the importance of resilient supply chains and prompted greater focus on localized production. Organizations are responding through enhanced logistics partnerships, bulk procurement agreements, and diversified sourcing to uphold continuity in research and therapeutic supply.

Human Fibroblast Growth Factor 2: Research Methodology & Data Sources

This analysis employs in-depth primary interviews with industry scientists, process engineers, and regulatory specialists, complemented by structured questionnaires sent to leading academic and commercial labs. Insights were validated through workshops and triangulated with peer-reviewed publications, patent filings, and regulatory guidelines. Advanced analytics supported correlations of production, delivery, and clinical parameters to ensure robust, actionable insights.

Why This Report Matters

  • Offers senior leaders a comprehensive view of global Human Fibroblast Growth Factor 2 market dynamics and strategic opportunities for growth.
  • Delivers actionable recommendations to strengthen production efficiency, supply chain resilience, and regulatory engagement strategies.
  • Enables more informed decisions on collaborations, investments, and product positioning in a rapidly evolving therapeutic landscape.

Conclusion

Human Fibroblast Growth Factor 2 stands at a critical inflection point, driven by innovation across production, delivery, and application arenas. Strategic collaboration and robust methodologies will remain vital as stakeholders seek to unlock the molecule’s full therapeutic and commercial potential.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in recombinant FGF2 production via plant-based expression systems for cost-effective manufacturing
5.2. Integration of FGF2 in 3D bioprinting bioinks for personalized tissue engineering scaffolds
5.3. Development of sustained-release FGF2-loaded nanoparticles for targeted wound healing applications
5.4. Clinical trial expansion of FGF2 in cardiac regeneration after myocardial infarction in elderly patients
5.5. Regulatory approval pathways for FGF2-based ophthalmic therapies addressing corneal repair challenges
5.6. Strategic partnerships between biotech startups and global CDMOs for scalable FGF2 manufacturing solutions
5.7. Optimization of FGF2 glycosylation profiles to enhance stability and activity in stem cell proliferation cultures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Fibroblast Growth Factor 2 Market, by Application
8.1. Introduction
8.2. Cancer Therapy
8.3. Cosmetic
8.4. Drug Delivery
8.4.1. Hydrogel Delivery
8.4.2. Liposome Delivery
8.4.3. Nanoparticle Delivery
8.5. Research
8.6. Tissue Engineering
8.6.1. Bone Regeneration
8.6.2. Cardiac Regeneration
8.6.3. Neural Regeneration
8.6.4. Skin Regeneration
9. Human Fibroblast Growth Factor 2 Market, by Expression System
9.1. Introduction
9.2. ChO Cells
9.3. E Coli
9.4. Insect Cells
9.5. Yeast
10. Human Fibroblast Growth Factor 2 Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Hospitals And Clinics
10.6. Pharmaceutical Companies
11. Human Fibroblast Growth Factor 2 Market, by Product Form
11.1. Introduction
11.2. Liquid Form
11.3. Lyophilized Powder
12. Human Fibroblast Growth Factor 2 Market, by Purity Grade
12.1. Introduction
12.2. 95 To 99 Percent
12.3. Less Than 95 Percent
12.4. More Than 99 Percent
13. Human Fibroblast Growth Factor 2 Market, by Type
13.1. Introduction
13.2. Natural Human FGF2
13.3. Recombinant Human FGF2
14. Americas Human Fibroblast Growth Factor 2 Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Fibroblast Growth Factor 2 Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Fibroblast Growth Factor 2 Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. STEMCELL Technologies Inc.
17.3.6. Promega Corporation
17.3.7. Lonza Group AG
17.3.8. RayBiotech Inc.
17.3.9. Sino Biological Inc.
17.3.10. ProSpec-Tany Technogene Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET: RESEARCHAI
FIGURE 28. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CANCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COSMETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COSMETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY HYDROGEL DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY HYDROGEL DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LIPOSOME DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LIPOSOME DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CARDIAC REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CARDIAC REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NEURAL REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NEURAL REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY SKIN REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY SKIN REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY E COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY E COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY 95 TO 99 PERCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY 95 TO 99 PERCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LESS THAN 95 PERCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY LESS THAN 95 PERCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY MORE THAN 99 PERCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY MORE THAN 99 PERCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NATURAL HUMAN FGF2, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY NATURAL HUMAN FGF2, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY RECOMBINANT HUMAN FGF2, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY RECOMBINANT HUMAN FGF2, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 129. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 130. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 131. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 220. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 221. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 226. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 227. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 236. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 237. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 238. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 239. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 242. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 243. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 266. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 267. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 268. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 269. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 270. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 271. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 274. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 275. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 276. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 277. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 282. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 283. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 284. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 285. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 286. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 287. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 290. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 291. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. SPAIN HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES HUMAN FIBROBLAST GROWTH FACTOR 2 MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Fibroblast Growth Factor 2 market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Abcam plc
  • STEMCELL Technologies Inc.
  • Promega Corporation
  • Lonza Group AG
  • RayBiotech Inc.
  • Sino Biological Inc.
  • ProSpec-Tany Technogene Ltd.

Related Topics

Related Reports

Fibroblast Growth Factors Market - Global Forecast 2025-2030 - Product Image

Fibroblast Growth Factors Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025 - Product Image

Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025

  • Clinical Trials
  • 90 Pages
  • Global
From
Fibroblast Growth Factors - Global Strategic Business Report - Product Image

Fibroblast Growth Factors - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Image

Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • 70 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.